XML 102 R42.htm IDEA: XBRL DOCUMENT v3.25.0.1

Share-based compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangements [Abstract]

Schedule of Expense Associated With Each Component

Share-based compensation expense associated with each component is as follows for the year ended December 31:

									December 31,
															2024						2023
															$						$
Stock options															2,968						2,330
DSUs															1,009						987
RSUs															3,258						2,625
ESPP															95						107
															7,330						6,049

The following table presents share-based compensation expense by function for the year ended December 31:

									December 31,
															2024						2023
															$						$
Cost of revenue															334						212
General and administrative															4,671						3,423
Sales and marketing															1,514						1,461
Research and development															811						953
															7,330						6,049

Schedule of Changes in Stock Options

The changes in the number of stock options during the years ended December 31, 2024 and 2023 were as follows:

			2024												2023
			Number of options						Weighted average exercise price						Number of options						Weighted average exercise price
			#						C$						#						C$
Options outstanding – January 1			825,091						28.37						1,349,001						13.60
Options granted			211,350						61.80						245,215						52.73
Options forfeited			(63,540)						62.98						(127,729)						44.25
Options exercised			(144,142)						28.99						(641,396)						3.46
Options expired			(1,117)						52.46						—						—
Options outstanding – December 31			827,642						34.11						825,091						28.37
Options exercisable – December 31			484,483						18.46						456,218						13.85

Schedule of Number and Weighted Average Remaining Contractual Life of Stock Options Outstanding and Exercisable

The weighted average fair value of share options granted during the years ended December 31, 2024 and 2023 was estimated at the date of grant using the Black-Scholes option pricing model using the following inputs:

			2024						2023
			C$						C$
Weighted average stock price valuation			$	61.80					$	52.73
Weighted average exercise price			$	61.80					$	52.73
Risk-free interest rate			3.54		%				3.14		%
Expected life in years			4.5						4.5
Expected dividend yield			—		%				—		%
Volatility			57		%				64		%
Weighted average fair value of options issued			$	30.76					$	28.44

The following table is a summary of the Company’s stock options outstanding as at December 31, 2024:

Options outstanding																		Options exercisable
Exercise price range						Number outstanding						Weighted average remaining contractual life (years)						Exercise price range						Number exercisable
C$						#						#						C$						#
0.0001 - 1.09						234,120						1.73						0.0001 - 1.09						234,120
8.86 - 11.06						23,985						5.99						8.86 - 11.06						21,242
15.79 - 16.00						93,947						4.77						15.79 - 16.00						93,947
26.43 - 60.00						385,966						4.71						26.43 - 60.00						125,813
60.01 - 95.12						89,624						4.50						60.01 - 95.12						9,361
						827,642						3.89												484,483

The following table is a summary of the Company’s stock options outstanding as at December 31, 2023:

Options outstanding																		Options exercisable
Exercise price range						Number outstanding						Weighted average remaining contractual life (years)						Exercise price range						Number exercisable
C$						#						#						C$						#
0.0001 - 1.09						235,320						2.73						0.0001 - 1.09						235,320
8.86 - 11.06						26,185						7.01						8.86 - 11.06						9,500
15.79 - 16.00						179,354						5.77						15.79 - 16.00						137,885
26.43 - 60.00						348,091						5.48						26.43 - 60.00						58,511
60.01 - 95.12						36,141						3.66						60.01 -95.12						15,002
						825,091						5.18												456,218

Schedule of Stock Options Outstanding and Exercisable by Range of Exercise Prices

The following table is a summary of the Company’s stock options outstanding as at December 31, 2024:

Options outstanding																		Options exercisable
Exercise price range						Number outstanding						Weighted average remaining contractual life (years)						Exercise price range						Number exercisable
C$						#						#						C$						#
0.0001 - 1.09						234,120						1.73						0.0001 - 1.09						234,120
8.86 - 11.06						23,985						5.99						8.86 - 11.06						21,242
15.79 - 16.00						93,947						4.77						15.79 - 16.00						93,947
26.43 - 60.00						385,966						4.71						26.43 - 60.00						125,813
60.01 - 95.12						89,624						4.50						60.01 - 95.12						9,361
						827,642						3.89												484,483

The following table is a summary of the Company’s stock options outstanding as at December 31, 2023:

Options outstanding																		Options exercisable
Exercise price range						Number outstanding						Weighted average remaining contractual life (years)						Exercise price range						Number exercisable
C$						#						#						C$						#
0.0001 - 1.09						235,320						2.73						0.0001 - 1.09						235,320
8.86 - 11.06						26,185						7.01						8.86 - 11.06						9,500
15.79 - 16.00						179,354						5.77						15.79 - 16.00						137,885
26.43 - 60.00						348,091						5.48						26.43 - 60.00						58,511
60.01 - 95.12						36,141						3.66						60.01 -95.12						15,002
						825,091						5.18												456,218

Schedule of Number of DSUs and RSUs Granted

DSUs

The following table presents information on the Company’s DSUs for the years presented:

			#
DSUs – December 31, 2022			87,222
Granted (at $43.93 - $53.15 per unit)			28,354
DSUs – December 31, 2023			115,576
Granted (at C$51.95 - C$68.04 per unit)			27,019
DSUs - December 31, 2024			142,595

RSUs

The following table presents information on the Company’s RSUs for the years presented:

			#
RSUs – December 31, 2022			103,626
Granted (at C$43.55 - $69.71 per unit)			132,254
Released (at C$40.30 - $86.38 per unit)			(24,359)
Forfeited (at C$42.24 - $86.38 per unit)			(51,371)
RSUs – December 31, 2023			160,150
Granted (at C$50.39 - C$73.54 per unit)			105,175
Released (at C$40.30 - $86.38 per unit)			(65,997)
Forfeited (at C$40.94 - $86.38 per unit)			(27,684)
RSUs - December 31, 2024			171,644

X

- Definition

Share-Based Payment Arrangements [Abstract]

+ References

No definition available.

+ Details

Name:	docebo_ShareBasedPaymentArrangementsAbstract
Namespace Prefix:	docebo_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options).

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Name IFRS
-Number 2
-IssueDate 2024-01-01
-Paragraph 45
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2024-01-01
-Paragraph 45
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2024-01-01
-Paragraph 45
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the range of exercise prices for outstanding share options.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2024-01-01
-Paragraph 45
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The explanation that enables users of financial statements to understand the effect of share-based payment transactions on the entity's profit (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2024-01-01
-Paragraph 50
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_50&doctype=Standard
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration